Macedonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
glucosamine/рак
Врската е зачувана во таблата со исечоци
9 резултати
Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
This application is the National Phase of PCT/KR2006/005229 filed on Dec. 6, 2006, which claims priority under 35 U.S.C. 119(a) to Patent Application Nos. 10-2006-0054519 and 10-2006-0119620 filed in Republic of Korea on Jun. 16, 2006 and Nov. 30, 2006, respectively. All of the above applications
Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for suppressing side-effect of radiotherapy and chemotherapy
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
TECHNICAL FIELD
The present invention relates to the use of N-acetyl-D-glucosamine and pharmaceutical acceptable salts thereof in the manufacture of a medicament for inhibiting the side effect of radio-chemical therapy.
BACKGROUND ART
After accepting radio-chemical treatment, patients with neoplasm
Dietary supplement formulation for controlling inflammation and cancer
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
FIELD OF THE INVENTION
The present invention relates to new dietary supplement compositions comprising 5-LOXIN, glucosamine hydrochloride and curcuminoids, and optionally bromelain, chondroitin, methylsulfonylmethane, resveratrol, white Willow (Salix alba), ginger, and quercetin.
BACKGROUND OF THE
N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
Background of the Invention
The present invention relates to acyl derivatives of glucosamines with amino acids or synthetic peptides, endowed with antitumor chemotherapeutic activity against transplanted tumors in animals, to pharmaceutical compositions containing said derivatives, to processes for
Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
The present invention relates to specific glucosamine disaccharides, in particular to 2-N- and/or 2'-N-acylated glucosamine disaccharides, wherein at least one of the acyl groups is branched, and to compounds comprising these disaccharides. The present invention relates further to methods for
Composition for treating hormonally-dependent cancers
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
N-Acyl derivatives of glucosamine having antitumor chemotherapeutic acitivity
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
BACKGROUND OF THE INVENTION
The present invention relates to N-acyl derivatives of an amino sugar with an oligopeptide, endowed with antitumor chemotherapeutic activity, and to pharmaceutical compositions containing said derivatives.
Antitumor chemotherapy has been and still is an object of
Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
This is a national-phase application of Int'l Appln. No. PCT/JP03/17030 under 35 U.S.C. 371, filed Dec. 26, 2003; the entire content of which is hereby incorporated by reference in this application.
TECHNICAL FIELD
The present invention relates to a novel nucleic acid, the nucleic acid for testing
Methods of screening for agonists and antagonists of the interaction between the human KIAA0001 receptor and ligands thereof
Само регистрираните корисници можат да преведуваат статии
Пријавете се / пријавете се
FIELD OF THE INVENTION
This invention relates to methods for discovering agonists and antagonists of the interaction between UDP-sugars (e.g.,UDP-glucose, UDP-galactose, UDP-glucuronic acid, and UDP-N-acetyl glucosamine) and their cellular receptor, human KIAA0001 receptor. The invention also
Најкомплетната база на податоци за лековити билки поддржана од науката
- Работи на 55 јазици
- Лекови од билки поддржани од науката
- Препознавање на билки по слика
- Интерактивна GPS мапа - означете ги билките на локацијата (наскоро)
- Прочитајте научни публикации поврзани со вашето пребарување
- Пребарувајте лековити билки според нивните ефекти
- Организирајте ги вашите интереси и останете во тек со истражувањето на новостите, клиничките испитувања и патентите
Напишете симптом или болест и прочитајте за билки што можат да помогнат, напишете билка и видете болести и симптоми против кои се користи.
* Сите информации се базираат на објавени научни истражувања
